Waters Corp Second Quarter Earnings Sneak Peek
S&P 500 (NYSE:SPY) component Waters Corp (NYSE:WAT) will unveil its latest earnings on Tuesday, July 26, 2011. Waters Corporation is an analytical instrument manufacturer, that designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products.
Waters Corp Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of $1.14 per share, a rise of 22.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.09. For the year, analysts are projecting net income of $4.87 per share, a rise of 19.1% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 8 cents, reporting profit of $1.02 per share against a mean estimate of net income of 94 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $450.9 million in revenue this quarter, a rise of 15.3% from the year ago quarter. Analysts are forecasting total revenue of $1.85 billion for the year, a rise of 12.8% from last year’s revenue of $1.64 billion.
Analyst Ratings: Analysts are bullish on Waters as eight analysts rate it as a buy, none rate it as a sell and eight rate it as a hold.
The company has now seen net income rise in three straight quarters. In the first quarter, net income rose 25.1% while it rose 21.6% in the fourth quarter of the last fiscal year and 24.7% in the third quarter of the last fiscal year.
Revenue has risen the past four quarters. Revenue increased 16.3% to $427.6 million in first quarter. The figure rose 12.8% in the fourth quarter of the last fiscal year from the year earlier, climbed 7.2% in the third quarter of the last fiscal year from the year-ago quarter and 7.8% in the second quarter of the last fiscal year.
Competitors to Watch: Bruker Corporation (NASDAQ:BRKR), Dionex Corporation (NASDAQ:DNEX), Beckman Coulter, Inc. (NYSE:BEC), PerkinElmer, Inc. (NYSE:PKI), Thermo Fisher Scientific Inc. (NYSE:TMO), Bio-Rad Laboratories, Inc. (NYSE:BIO), Harvard Bioscience, Inc. (NASDAQ:HBIO), Cepheid (NASDAQ:CPHD), and Mettler-Toledo Intl. Inc. (NYSE:MTD).
Stock Price Performance: During April 25, 2011 to July 20, 2011, the stock price had risen $5.63 (6.2%) from $90.73 to $96.36. The stock price saw one of its best stretches over the last year between September 7, 2010 and September 22, 2010 when shares rose for 12-straight days, rising 10.3% (+$6.60) over that span. It saw one of its worst periods between December 20, 2010 and December 31, 2010 when shares fell for nine-straight days, falling 3.4% (-$2.76) over that span. Shares are up $18.65 (+24%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!